Amylyx Pharmaceuticals, Inc. AMLX Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Amylyx Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s asset turnover?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported asset turnover of 0× in Q4 2025.
- How has Amylyx Pharmaceuticals, Inc.'s asset turnover changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s asset turnover decreased by 100.0% year-over-year, from 0.2× to 0×.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s asset turnover?
- Over 2 years (2023 to 2025), Amylyx Pharmaceuticals, Inc.'s asset turnover has grown at a -100.0% compound annual growth rate (CAGR), from 0.8× to 0×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.